EcoDrugPlus

Receptor (Tnfrsf)-Interacting Serine-Threonine Kinase 1

Ensembl ID : ENSMSIG00000003307
Gene Symbol: RIPK1
1 Cross references
212 Possible Orthologues:

Regulatory Associated Protein Of Mtor, Complex 1

Ensembl ID : ENSMSIG00000015682
Gene Symbol: RPTOR
1 Cross references
224 Possible Orthologues:

Renin 1 Structural

Ensembl ID : ENSMSIG00000022363
Gene Symbol: REN1
1 Cross references
231 Possible Orthologues:

Ret Proto-Oncogene

Ensembl ID : ENSMSIG00000005075
Gene Symbol: RET
1 Cross references
219 Possible Orthologues:

Retinoic Acid Receptor, Alpha

Ensembl ID : ENSMSIG00000026176
Gene Symbol: RARA
1 Cross references
346 Possible Orthologues:

Retinoic Acid Receptor, Beta

Ensembl ID : ENSMSIG00000014994
Gene Symbol: RARB
1 Cross references
465 Possible Orthologues:

Retinoic Acid Receptor, Gamma

Ensembl ID : ENSMSIG00000025751
Gene Symbol: RARG
1 Cross references
461 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSMSIG00000012091
Gene Symbol: RXRB
1 Cross references
249 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSMSIG00000006785
Gene Symbol: RXRG
1 Cross references
288 Possible Orthologues:

Ribosomal Protein L10a

Ensembl ID : ENSMSIG00000008210
Gene Symbol: RPL10A
1 Cross references
173 Possible Orthologues:

Ribosomal Protein L18

Ensembl ID : ENSMSIG00000018122
Gene Symbol: RPL18
1 Cross references
246 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSMSIG00000032086
Gene Symbol: RPL18A
1 Cross references
189 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).